← All organizations

South African Tuberculosis Vaccine Initiative (SATVI)

Academic/HospitalWebsite ↗

Also known as: South African Tuberculosis Vaccine Initiative | Study Principal Investigator South African Tuberculosis Vaccine Initiative

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jan 31, 2024

Timeline

2000s

Jan 1, 2001
South African Tuberculosis Vaccine Initiative (SATVI)— Founded

Drugs by trial phase (12 distinct, 12 trials)

Phase 4 (1 own, 0 via acquisition)

bacille calmette-guerin

Phase 3 (2 own, 0 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (17)

NCT06050356CollaboratorPhase 1Jan 31, 2024
NCT05947890Study chairPhase 2Jan 15, 2024
NCT05947890OfficialPhase 2Jan 15, 2024
NCT03536117Overall official - principal investigatorPhase 2Jul 31, 2018
NCT03536117CollaboratorPhase 2Jul 31, 2018
NCT03265977CollaboratorPhase 2Jun 30, 2018
NCT02933281CollaboratorPhase 1/Phase 2Aug 1, 2017
NCT02735590CollaboratorPhase 2/Phase 3Jul 1, 2016
NCT02735590Overall official - principal investigatorPhase 2/Phase 3Jul 1, 2016
NCT02729571CollaboratorPhase 1/Phase 2Sep 1, 2015
NCT02729571Overall official - principal investigatorPhase 1/Phase 2Sep 1, 2015
NCT02391415CollaboratorPhase 2Jun 1, 2015
NCT02465216Overall official - principal investigatorPhase 2Jun 1, 2015
NCT02465216CollaboratorPhase 2Jun 1, 2015
NCT01927159CollaboratorPhase 1Sep 1, 2013

Details

Founded: Cape Town, ZA Jan 1, 2001
Last known activity: Jan 31, 2024